pregnancy outcome. Pregnancy-related condition, unspecified
Conditions
Interventions
Treatment - Drugs
Intervention 1: Multivitamin, one oral tablet as well as placebo one tablet, daily, from 13th week of pregnancy until delivery. Intervention 2: Multivitamin, one oral tablet as well 30 mg elemental ir
Multivitamin, one oral tablet as well as placebo one tablet, daily, from 13th week of pregnancy until delivery
Multivitamin, one oral tablet as well 30 mg elemental iron, daily, from 13th week of pregnancy until delivery
Sponsors
Vice Chancellor for Research
Eligibility
Sex/Gender
Female
Age
15 Years to 45 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: women who were at the first trimester of pregnancy with single fetus, Hb > 12 gr/dl, not receiving iron containing supplements in the last month, BP < 140/90 mmHg, Exclusion criteria: Hb less than 10.5 gr/dl or less than 11 gr/dl at the end of 2nd and 3rd trimesters respectively, miscarriage of current pregnancy, abnormality of the fetus, loss to follow-up
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Preeclampsia. Timepoint: before intervention and every month during pregnancy. Method of measurement: blood pressure checking and urine protein test.;Preterm labor. Timepoint: every month after 20 w of pregnancy. Method of measurement: control of uterine contractions and cervical examination.;PROM. Timepoint: monthly prenatal care. Method of measurement: declaring membrane rupture by patient and nitrazin test.;Neonatal birth weight. Timepoint: immediately after birth. Method of measurement: by precise scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Maternal anemia. Timepoint: monthly prenatal care. Method of measurement: Hb,Hct test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactElaheh Ouladsahebmadarek
Tabriz University of Medical Sciences
Outcome results
None listed